3 results
Approved WMOCompleted
To evaluate the safety and performance of the Paclitaxel Eluting Balloon Balloon mounted with a Cobalt Chromium stent (DEBS) and Paclitaxel Eluting Balloon (DEB) in patients with de novo coronary artery disease.
Approved WMOCompleted
To assess the local and systemic safety and tolerability of continued ABBV-951 treatment delivered as a CSCI for 24 hours daily.
Approved WMOCompleted
To assess the local and systemic safety and tolerability of ABBV-951 delivered as a CSCI for 24 hours daily for up to 52 weeks.